UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk

Frontiers in medicine, 2023-10, Vol.10, p.1319904-1319904

2023

Volltextzugriff (PDF)

Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology

Scientific reports, 2021-12, Vol.11 (1), p.23823-23823, Article 23823

2021

Volltextzugriff (PDF)

Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study

Hematological oncology, 2022-10, Vol.40 (4), p.645-657

2022

Volltextzugriff (PDF)

The Tumor Microenvironment of DLBCL in the Computational Era

Frontiers in oncology, 2020-03, Vol.10, p.351-351

2020

Volltextzugriff (PDF)

Immature dendritic cells in multiple myeloma are prone to osteoclast‐like differentiation through interleukin‐17A stimulation

British journal of haematology, 2013-06, Vol.161 (6), p.821-831

2013

Volltextzugriff (PDF)

Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi

Cancers, 2022-01, Vol.14 (3), p.519

2022

Volltextzugriff (PDF)

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi

Frontiers in oncology, 2023-03, Vol.13, p.1120967-1120967

2023

Volltextzugriff (PDF)

Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma

Current oncology (Toronto), 2022-08, Vol.29 (9), p.6115-6124

2022

Volltextzugriff (PDF)

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas

Cells (Basel, Switzerland), 2021-03, Vol.10 (3), p.675

2021

Volltextzugriff (PDF)

A Decision‐tree Approach to Stratify DLBCL Risk Based on Stromal and Immune Microenvironment Determinants

HemaSphere, 2023-04, Vol.7 (4), p.e862-n/a

2023

Volltextzugriff (PDF)

Primary, Bilateral and Diffuse Renal Non-Hodgkin’s Lymphoma in a Young Woman Suffering from Turner Syndrome

Journal of personalized medicine, 2021-07, Vol.11 (7), p.644

2021

Volltextzugriff (PDF)

Bone‐Resorbing Cells in Multiple Myeloma: Osteoclasts, Myeloma Cell Polykaryons, or Both?

The oncologist (Dayton, Ohio), 2009-03, Vol.14 (3), p.264-275

2009

Volltextzugriff (PDF)

Oversecretion of Cytokines and Chemokines in Lupus Nephritis Is Regulated by Intraparenchymal Dendritic Cells

Annals of the New York Academy of Sciences, 2009-09, Vol.1173 (1), p.449-457

2009

Volltextzugriff (PDF)

SurvIAE: Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression data

Computer methods and programs in biomedicine, 2024-02, Vol.244, p.107966-107966, Article 107966

2024

Volltextzugriff (PDF)

A Digital Gene-Expression Signature Supports Mediastinal Gray Zone Lymphoma Stratification within Classical Hodgkin or Primary Mediastinal B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.9312-9313

2022

Volltextzugriff (PDF)

In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells

British journal of haematology, 2012-06, Vol.157 (5), p.586-598

2012

Volltextzugriff (PDF)

Mesenchymal stem cells: a new promise in anticancer therapy

Stem cells and development, 2011-01, Vol.20 (1), p.1

2011

Volltextzugriff (PDF)

Oversecretion of cytokines and chemokines in lupus nephritis is regulated by intraparenchymal dendritic cells: a review

Annals of the New York Academy of Sciences, 2009-09, Vol.1173 (1), p.449-457

2009

Volltextzugriff (PDF)

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment

Oncotarget, 2019-06, Vol.10 (40), p.3991-3993

2019

Volltextzugriff (PDF)

P-383 A 16-gene signature reflecting tumor microenvironment predicts the risk of multiple myeloma patients treated by bortezomib-based therapies

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S251-S252

2023

Volltextzugriff (PDF)

A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression

Stem cells and development, 2015-06, Vol.24 (12), p.1457

2015

Volltextzugriff (PDF)

Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells

BMC cancer, 2015-10, Vol.15 (1), p.692-692, Article 692

2015

Volltextzugriff (PDF)

Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro

Experimental hematology, 2011-07, Vol.39 (7), p.773-783.e1

2011

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Humans
(21)
Hematology
(17)
Oncology
(11)
Multiple Myeloma
(7)
Medicine, Research & Experimental
(6)
Research & Experimental Medicine
(6)
Animals
(5)
Gene Expression
(5)
Gene Expression Profiling
(5)
Lymphoma
(5)
Transplantation
(5)
Tumor Microenvironment
(5)
Cell Biology
(4)
Diffuse Large B-Cell Lymphoma
(4)
Mesenchymal Stem Cell Transplantation
(4)
Osteoclasts - Metabolism
(4)
Prognosis
(4)
Tumors
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk

Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology

Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study

The Tumor Microenvironment of DLBCL in the Computational Era

Immature dendritic cells in multiple myeloma are prone to osteoclast‐like differentiation through interleukin‐17A stimulation

Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi

Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas

A Decision‐tree Approach to Stratify DLBCL Risk Based on Stromal and Immune Microenvironment Determinants

Primary, Bilateral and Diffuse Renal Non-Hodgkin’s Lymphoma in a Young Woman Suffering from Turner Syndrome

Bone‐Resorbing Cells in Multiple Myeloma: Osteoclasts, Myeloma Cell Polykaryons, or Both?

Oversecretion of Cytokines and Chemokines in Lupus Nephritis Is Regulated by Intraparenchymal Dendritic Cells

SurvIAE: Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression data

A Digital Gene-Expression Signature Supports Mediastinal Gray Zone Lymphoma Stratification within Classical Hodgkin or Primary Mediastinal B-Cell Lymphoma

Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care)

In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells

Mesenchymal stem cells: a new promise in anticancer therapy

Validation of Argo (Automatic record generator for Onco-Hematology), a New App Supporting the Automatic Conversion of Paper-Based Pathology Reports in Standardized Ecrfs

Oversecretion of cytokines and chemokines in lupus nephritis is regulated by intraparenchymal dendritic cells: a review

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment

P-383 A 16-gene signature reflecting tumor microenvironment predicts the risk of multiple myeloma patients treated by bortezomib-based therapies

A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression

Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells

Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro

Suchergebnisse filtern